Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 267
Gene Symbol: AMFR
AMFR 		0.300 Biomarker phenotype CTD_human Paclitaxel-based second-line therapy for patients with advanced chemotherapy-resistant bladder carcinoma (M1): a clinical Phase II study. 9241080 1997
Entrez Id: 1081
Gene Symbol: CGA
CGA 		0.300 Biomarker phenotype CTD_human Hemiplegia after thyrotropin alfa in a hypothyroid patient with thyroid carcinoma metastatic to the brain. 10566621 1999
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.300 Biomarker phenotype CTD_human HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes. 10897039 2000
Entrez Id: 847
Gene Symbol: CAT
CAT 		0.300 Biomarker phenotype CTD_human Manganese superoxide dismutase and catalase are coordinately expressed in the alveolar region in chronic interstitial pneumonias and granulomatous diseases of the lung. 10673208 2000
Entrez Id: 6648
Gene Symbol: SOD2
SOD2 		0.300 Biomarker phenotype CTD_human Manganese superoxide dismutase and catalase are coordinately expressed in the alveolar region in chronic interstitial pneumonias and granulomatous diseases of the lung. 10673208 2000
Entrez Id: 847
Gene Symbol: CAT
CAT 		0.300 Therapeutic phenotype CTD_human Manganese superoxide dismutase and catalase are coordinately expressed in the alveolar region in chronic interstitial pneumonias and granulomatous diseases of the lung. 10673208 2000
Entrez Id: 6648
Gene Symbol: SOD2
SOD2 		0.300 Therapeutic phenotype CTD_human Manganese superoxide dismutase and catalase are coordinately expressed in the alveolar region in chronic interstitial pneumonias and granulomatous diseases of the lung. 10673208 2000
Entrez Id: 847
Gene Symbol: CAT
CAT 		0.300 Biomarker phenotype CTD_human Expression and prognostic significance of catalase in malignant mesothelioma. 11283936 2001
Entrez Id: 6648
Gene Symbol: SOD2
SOD2 		0.300 Biomarker phenotype CTD_human Expression and prognostic significance of catalase in malignant mesothelioma. 11283936 2001
Entrez Id: 6648
Gene Symbol: SOD2
SOD2 		0.300 Therapeutic phenotype CTD_human Expression and prognostic significance of catalase in malignant mesothelioma. 11283936 2001
Entrez Id: 847
Gene Symbol: CAT
CAT 		0.300 Therapeutic phenotype CTD_human Expression and prognostic significance of catalase in malignant mesothelioma. 11283936 2001
Entrez Id: 540
Gene Symbol: ATP7B
ATP7B 		0.300 Biomarker phenotype CTD_human Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP. 12216079 2002
Entrez Id: 3265
Gene Symbol: HRAS
HRAS 		0.300 Biomarker phenotype CTD_human Occurrence of H-ras codon 61 CAA to AAA mutation during mouse liver tumor progression. 12082015 2002
Entrez Id: 2247
Gene Symbol: FGF2
FGF2 		0.300 Biomarker phenotype CTD_human An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer. 12644816 2003
Entrez Id: 540
Gene Symbol: ATP7B
ATP7B 		0.300 Biomarker phenotype CTD_human Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin. 12509969 2003
Entrez Id: 354
Gene Symbol: KLK3
KLK3 		0.300 Biomarker phenotype CTD_human An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer. 12644816 2003
Entrez Id: 6648
Gene Symbol: SOD2
SOD2 		0.300 Therapeutic phenotype CTD_human A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis. 16081686 2005
Entrez Id: 10549
Gene Symbol: PRDX4
PRDX4 		0.300 Biomarker phenotype CTD_human A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis. 16081686 2005
Entrez Id: 6649
Gene Symbol: SOD3
SOD3 		0.300 Biomarker phenotype CTD_human A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis. 16081686 2005
Entrez Id: 6648
Gene Symbol: SOD2
SOD2 		0.300 Biomarker phenotype CTD_human A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis. 16081686 2005
Entrez Id: 10628
Gene Symbol: TXNIP
TXNIP 		0.300 Biomarker phenotype CTD_human A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis. 16081686 2005
Entrez Id: 847
Gene Symbol: CAT
CAT 		0.300 Therapeutic phenotype CTD_human A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis. 16081686 2005
Entrez Id: 847
Gene Symbol: CAT
CAT 		0.300 Biomarker phenotype CTD_human A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis. 16081686 2005
Entrez Id: 10935
Gene Symbol: PRDX3
PRDX3 		0.300 Biomarker phenotype CTD_human A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis. 16081686 2005
Entrez Id: 596
Gene Symbol: BCL2
BCL2 		0.300 Biomarker phenotype CTD_human A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis. 16081686 2005